The FDA has recalled medicine used to control blood pressure because it contains contaminants that might be carcinogenic. In the quest for more profit, a Chinese manufacturer broke the rules, thinking the ends justified the means.
A dearth of truth in medical advertising is probably our greatest public health threat. With consumers bombarded by spurious claims, our agencies need to be proactive, not reactive in protecting the public.
